Dexmedetomidine sedation after stroke clot removal
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This Phase 4 study tests whether using a specific calming medicine (dexmedetomidine) for a longer period after a successful clot-removal procedure helps people do better in the long term. It may help improve outcomes after ischemic stroke where the clot is successfully treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an acute ischemic stroke (a blocked blood vessel) and underwent mechanical thrombectomy.
- Clot-removal result was good (blood flow score mTICI 2b or 3).
- Your current symptoms score was between 2 and 25 (NIHSS).
- Before this stroke, you could function well enough (mRS before stroke was under 3).
- Your stroke area did not bleed in the last 6 weeks, and you did not have a stent placed in the responsible vessel before.
- You must be able to have the procedure with local anesthesia/sedation, and you can sign consent (you or a legal representative).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different types of calming medicine (sedation) after a procedure to remove a brain blood clot. It aims to see whether post-procedure sedation can improve recovery in people with a serious type of stroke.
This study compares two types of light sedation (medication to help you relax) during a procedure to remove a blood clot in the brain after a stroke. The goal is to find which sedation method helps patients recover better.
This trial studies whether ketamine given soon after an ischemic stroke (blocked blood flow) can reduce early brain injury. It may help some people by limiting harmful brain reactions after stroke.
This trial tests if giving a steroid (methylprednisolone) directly into the brain artery after successful clot removal improves recovery. It is for people who had a large stroke in the front part of the brain and got the clot out within 24 hours.
This trial tests if a sublingual (under the tongue) medication called Edaravone Dexborneol can help stroke patients who are being transferred from one hospital to another for a specialized procedure to remove a clot.
This trial looks at whether a medication called dexmedetomidine can reduce “postoperative delirium,” a temporary period of confusion after awake brain surgery. If you have the type of surgery the study focuses on, this could help your recovery and mental clarity afterward.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.